Bomedemstat
Imago BioSciences
[]
$imgo imago biosciences presents positive data from ongoing phase 2 study of bomedemstat in essential thrombocythemia at eha 2022 stock news alerts in bio
Over 500 members. DM us for our premium stock alerts.